SCHEMBL5867524

SCHEMBL5867524

O=C(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)Nc1cc(C2CC2)n[nH]1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 10/20 0.49
CCNA2 P20248 9/20 0.49
CCNA1 P78396 9/20 0.49
CCNE1 P24864 1/20 0.45
CDK9 P50750 1/20 0.45
CDK5 Q00535 1/20 0.45
CDK5R1 Q15078 1/20 0.45
NLRP3 Q96P20 1/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
MCHR1 Q99705 1/20 0.42
SIGMAR1 Q99720 2/20 0.42
P2RX7 Q99572 2/20 0.41
GSK3B P49841 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5867724 0.97 CDK2 (0.48) CDK2CCNA2CCNA1NLRP3HDAC1
SCHEMBL5867593 0.86 CDK2 (0.65) CDK2CCNA2CCNA1CCNE1CDK9
SCHEMBL5867687 0.84 CDK2 (0.49) CDK2CCNA2CCNA1CCNE1CDK9
SCHEMBL5867952 0.83 CDK2 (0.48) CDK2CCNA2CCNA1CCNE1CDK9
SCHEMBL5867496 0.83 LMNA (0.50) CDK2CCNA2CCNA1CCNE1CDK5
SCHEMBL5867749 0.82 CDK2 (0.49) CDK2CCNA2CCNA1CCNE1CDK9
SCHEMBL5867860 0.82 CDK2 (0.49) CDK2CCNA2CCNA1CCNE1CDK9
SCHEMBL24413610 0.81 CDK2 (0.47) CDK2CCNA2CCNA1CCNE1CDK9
SCHEMBL5867926 0.81 CDK2 (0.62) CDK2CCNA2CCNA1CCNE1CDK9
SCHEMBL5867835 0.80 CDK2 (0.76) CDK2CCNA2CCNA1CCNE1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034049-B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents PHARMACIA ITALIA S.P.A. (IT) 2006-04-25 US disclosed
EP-1202733-B1 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-10-05 EP disclosed